CAMBRIDGE, Mass., Feb. 23, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins, Executive Vice President and Chief Business Officer, will be participating in a panel discussion at the SIGnificant Investment Options in Healthcare Conference hosted by Susquehanna International Group. The panel discussion titled "Biotech and Pharma M&A Consolidation Theme Accelerates" will take place on Thursday, March 1, 2007 at 3:00 p.m. EST at the Omni Berkshire Hotel in New York City.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.ipi.com and will be archived on the website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients first-in-class or best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.ipi.com.
INFI-G